Laplace Interventional Secures Series C Funding for Tricuspid Valve Technology

Laplace Interventional completes Series C financing round led by a global strategic investor, with new and existing investors participating. The funds will be utilized for the completion of the Early Feasibility Study (EFS) and progression towards a pivotal study for the transcatheter tricuspid valve technology.